EFFECTS OF AN ORALLY ACTIVE CONVERTING ENZYME-INHIBITOR (YS-980) ON RENAL-FUNCTION IN DOGS

被引:0
|
作者
ABE, Y
MIURA, K
IMANISHI, M
YUKIMURA, T
KOMORI, T
OKAHARA, T
YAMAMOTO, K
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:166 / 170
页数:5
相关论文
共 50 条
  • [21] PHARMACODYNAMIC EFFECTS OF A SINGLE 10-MG DOSE OF THE ANGIOTENSIN CONVERTING ENZYME-INHIBITOR RAMIPRIL IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
    OCONPUJADAS, J
    DEBUSMANN, ER
    JANE, F
    LAHN, W
    IRMISCH, R
    MORA, J
    GROTSCH, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 : S45 - S48
  • [22] EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR YS980 ON PROSTAGLANDIN SYNTHESIS IN RABBIT KIDNEY MEDULLA SLICES
    FUJIMOTO, Y
    WADA, K
    KANEKO, M
    FUJITA, T
    BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (03) : 479 - 481
  • [23] EFFECT OF ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR (HOE 498) ON THE RENAL-FUNCTION IN ANESTHETIZED DOGS
    OMOSU, M
    HAYASHI, S
    SAKAGUCHI, T
    FOLIA PHARMACOLOGICA JAPONICA, 1986, 87 (06) : P80 - P80
  • [24] CLINICAL USE OF AN ORALLY ACTING CONVERTING ENZYME-INHIBITOR - CAPTOPRIL
    BRUNNER, HR
    GAVRAS, H
    WAEBER, B
    TEXTOR, SC
    TURINI, GA
    WAUTERS, JP
    HYPERTENSION, 1980, 2 (04) : 558 - 566
  • [25] ANTIHYPERTENSIVE EFFECTS AND PHARMACOKINETICS OF TEMOCAPRIL, AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR WITH PREFERENTIAL BILIARY-EXCRETION, IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
    TOKUNAGA, S
    OGUCHI, H
    HIGUCHI, M
    TOKOO, M
    MIYASAKA, M
    YAZAKI, K
    SAITO, H
    SHIOYA, H
    KAWAHARA, Y
    FURUTA, S
    DRUG INVESTIGATION, 1994, 7 (03): : 161 - 165
  • [26] HEMODYNAMICS OF ORALLY-ACTIVE CONVERTING ENZYME-INHIBITOR (SQ14225) IN HYPERTENSIVE PATIENTS
    CODY, RJ
    TARAZI, RC
    BRAVO, EL
    FOUAD, FM
    AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (02): : 402 - 402
  • [27] VASODILATOR ACTION OF ORALLY ACTIVE CONVERTING ENZYME-INHIBITOR (SQ 14225) IN SPONTANEOUSLY HYPERTENSIVE RAT
    MUIRHEAD, EE
    PREWITT, R
    BROOKS, B
    BROSIUS, WL
    CIRCULATION, 1977, 56 (04) : 214 - 214
  • [28] CGS-13945 - A NEW ORALLY ACTIVE ANGIOTENSIN CONVERTING ENZYME-INHIBITOR IN NORMAL VOLUNTEERS
    DESCOMBES, BJ
    TURINI, GA
    BRUNNER, HR
    PORCHET, M
    CHEN, DS
    SEN, SB
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (04) : 511 - 516
  • [29] EFFECT OF SA-446, AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, ON RENAL-FUNCTION IN ANESTHETIZED DOGS - SPECIAL REFERENCE TO ARACHIDONIC-ACID METABOLITES
    MIURA, K
    YUKIMURA, T
    IMANISHI, M
    OKAHARA, T
    ABE, Y
    YAMAMOTO, K
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (01) : 102 - 107
  • [30] SQ 14225, AN ORALLY ACTIVE ANGIOTENSIN I-CONVERTING ENZYME-INHIBITOR FOR THERAPY OF HYPERTENSION
    FAVRE, L
    FRAZER, MG
    HOLLIFIELD, JW
    CLINICAL RESEARCH, 1978, 26 (01): : A23 - A23